7QC-88090-50308
1 vaccination
8 coded responses
13 check-ins
8 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 226 / VA
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Dose 1 — Moderna
-
2021-03-02
Registered in v-safe
-
2021-03-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-03
Survey response — days 1–6 daily, dose 1MedDRA: Office visit — Feeling: Poor · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Primary physician for steroid injection and prescriptionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Itching · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-05
Survey response — days 1–6 daily, dose 1MedDRA: Swelling face — Feeling: Poor · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Swelling in faceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-08
Health check-in — day 7, dose 1Feeling: Fair · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-15
Survey response — day 14, dose 1MedDRA: Medical counselling, Pruritus, Rash — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Body rash came back after finishing steroids and had to re-start another course of steroids under physician advise (12 day taper of Prednisone for rash and itching). · Healthcare visit (other): Phone call to physician for prescriptionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-22
Survey response — day 21, dose 1MedDRA: Flushing, Hypersensitivity, Office visit, Paraesthesia, Rash — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Continued rash and prickly feeling along with flushing. · Healthcare visit (other): Primary care doctor visit. Referred to allergy/immunology-appt. tomorrow. Doctor spoke with health department doctor who felt that symptoms are that of allergic reaction to vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Report sent to call center — day 21, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-31
Survey response — day 28, dose 1MedDRA: Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Continued rash · Healthcare visit (other): Now under care of Allergist/ImmunologistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Report sent to call center — day 28, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-08
Survey response — day 35, dose 1MedDRA: Adverse reaction, Rash — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Continued rash, that worsened. · Healthcare visit (other): Still taking medications to try and control symptoms and under allergist/immunology careMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Report sent to call center — day 35, dose 1Get care from a doctor or other healthcare professionalno matching call case
-
2021-04-12
Survey response — day 42, dose 1MedDRA: Rash pruritic — Feeling: FairFree text: Worsening itching from rash.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-08
-
2022-03-01
Survey response — 12 months, dose 1MedDRA: Pulmonary embolism — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, HospitalizationFree text: Pulmonary EmbolismMedDRA releases: 2024-11 · check-in free text available
-
2022-03-01
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-03-02
Call successfulReported to VAERS voluntarily prior to GDIT contact
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Moderna |
Call center
5 call center cases
5 successful
VAERS report filed, before or during a call: 5
1 check-in flagged for a call with no call center case on record
Free text
Release 5 — days 1–6 daily, dose 1
Healthcare visit (other): Primary physician for steroid injection and prescription
Systemic reaction (other): Swelling in face
Release 5 — day 14, dose 1
Symptoms: Body rash came back after finishing steroids and had to re-start another course of steroids under physician advise (12 day taper of Prednisone for rash and itching).
Healthcare visit (other): Phone call to physician for prescription
Release 6 — day 21, dose 1
Symptoms: Continued rash and prickly feeling along with flushing.
Healthcare visit (other): Primary care doctor visit. Referred to allergy/immunology-appt. tomorrow. Doctor spoke with health department doctor who felt that symptoms are that of allergic reaction to vaccine.
Release 6 — day 28, dose 1
Symptoms: Continued rash
Healthcare visit (other): Now under care of Allergist/Immunologist
Release 7 — day 35, dose 1
Symptoms: Continued rash, that worsened.
Healthcare visit (other): Still taking medications to try and control symptoms and under allergist/immunology care
Release 7 — day 42, dose 1
Symptoms: Worsening itching from rash.
Release 11 — 12 months, dose 1
Symptoms: Pulmonary Embolism
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Adverse reaction | ✓ | ✓ | ✓ |
| HCVO | Hypersensitivity | ✓ | ✓ | ✓ |
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Flushing | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Pulmonary embolism | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SRO | Swelling face | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release